Oxytocin Reduces Methylphenidate-Induced Dorsal Striatal Dopamine Release in Male Rhesus Macaques
International Journal of Neuropsychopharmacology · 2024
DOI: 10.1093/ijnp/pyae056 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2024. Verfasst von Mary R Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Psychiatric Neuromodulation Service, Veterans Affairs Medical Center, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Methylphenidate, Oxytocin, Macaca mulatta, Dopamine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAAA NIH HHS, Division of Intramural Clinical and Biological Research.
Abstract (Originalsprache)
Background
Oxytocin is being evaluated as a potential treatment for psychostimulant use disorders. It is unknown what effect oxytocin has on dopamine signaling in response to psychostimulants in brain regions such as the striatum where oxytocin and dopamine interact to process natural rewards. We investigated the effect of oxytocin on striatal dopamine release stimulated by methylphenidate whose mechanism of action is analogous to that of cocaine.
Methods
We conducted an [11C] raclopride positron emission tomography study to assess striatal dopamine release in male rhesus macaques treated with oxytocin (80 IU) (administered via the intranasal [N = 5] and intravenous [N = 6] routes) followed by methylphenidate/[11C] raclopride.
Results
Oxytocin delivered by both routes significantly reduced methylphenidate-stimulated dopamine release in the dorsal striatum (caudate/putamen). These effects were, in part, evidenced by a reduction in dorsal striatal [11C] raclopride binding potential (increased dopamine release) following oxytocin administration.
Conclusions
The results provide translational and mechanistic evidence for the potential role of oxytocin as a treatment for psychostimulant use disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Psychiatric Neuromodulation Service, Veterans Affairs Medical Center, Washington, District of Columbia, USA.
- National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.
- Positron Emission Tomography Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
- Translational Gerontology Branch, National Institute on Aging, NIH Animal Center, Dickerson, Maryland, USA.
- Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA.
- Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Mary R Lee
Förderung
- NIA NIH HHS
- NIAAA NIH HHS
- Division of Intramural Clinical and Biological Research
- Office of Behavioral and Social Sciences Research
- NIH HHS
- Intramural Research Program
- Intramural NIH HHS
- NIDA NIH HHS
Zitieren
APA
Lee, M. R., Shokri Kojori, E., Dieckmann, W., Singley, E., Mattison, J. A., Herscovitch, P., & Leggio, L. (2024). Oxytocin Reduces Methylphenidate-Induced Dorsal Striatal Dopamine Release in Male Rhesus Macaques. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae056
Vancouver
Lee MR, Shokri Kojori E, Dieckmann W, Singley E, Mattison JA, Herscovitch P, et al. Oxytocin Reduces Methylphenidate-Induced Dorsal Striatal Dopamine Release in Male Rhesus Macaques. International Journal of Neuropsychopharmacology. 2024. doi:10.1093/ijnp/pyae056
BibTeX
@article{Lee2024,
author = {Lee, Mary R and Shokri Kojori, Ehsan and Dieckmann, William and Singley, Erick and Mattison, Julie A and Herscovitch, Peter and Leggio, Lorenzo},
title = {Oxytocin Reduces Methylphenidate-Induced Dorsal Striatal Dopamine Release in Male Rhesus Macaques},
journal = {International Journal of Neuropsychopharmacology},
year = {2024},
doi = {10.1093/ijnp/pyae056}
}
EUVIMED